FFWM vs CVBF

For growth investors, First Foundation Inc.

(FFWM) is the stronger pick with 22. 2% revenue growth year-over-year, versus -2. 3% for CVB Financial Corp. (CVBF). CVB Financial Corp. (CVBF) offers the better valuation at 13. 6x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate First Foundation Inc. (FFWM) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, CVB Financial Corp.

is actually cheaper at 14. 3x.

Over the past 5 years, CVB Financial Corp.

(CVBF) delivered a total return of +11. 9%, compared to -72. 0% for First Foundation Inc. (FFWM). Over 10 years, the gap is even starker: CVBF returned +67. 4% versus FFWM's -34. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CVB Financial Corp.

(CVBF) is the lower-risk stock at 0. 94β versus First Foundation Inc. 's 1. 10β — meaning FFWM is approximately 18% more volatile than CVBF relative to the S&P 500. On balance sheet safety, CVB Financial Corp. (CVBF) carries a lower debt/equity ratio of 43% versus 176% for First Foundation Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), First Foundation Inc.

(FFWM) is pulling ahead at 22. 2% versus -2. 3% for CVB Financial Corp. (CVBF). On earnings-per-share growth, the picture is similar: CVB Financial Corp. grew EPS 5. 6% year-over-year, compared to -33. 3% for First Foundation Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CVB Financial Corp.

(CVBF) is the more profitable company, earning 32. 5% net margin versus -26. 4% for First Foundation Inc. — meaning it keeps 32. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CVBF leads at 43. 8% versus -12. 2% for FFWM. At the gross margin level — before operating expenses — CVBF leads at 79. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, CVB Financial Corp.

(CVBF) trades at 14. 3x forward P/E versus 45. 4x for First Foundation Inc. — 31. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVBF: 20. 0% to $24. 75.

In this comparison, CVBF (4.

0% yield) pays a dividend. FFWM does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CVB Financial Corp.

(CVBF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 4. 0% yield). Both have compounded well over 10 years (CVBF: +67. 4%, FFWM: -34. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: FFWM is a small-cap high-growth stock; CVBF is a small-cap deep-value stock. CVBF pays a dividend while FFWM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.